Apollo Hospitals Enterprise Ltd stock (INE438A01022): Q3 profit up 35% as shares hit 52-week high

Apollo Hospitals Enterprise Ltd shares have climbed to a fresh 52-week high after the hospital chain reported a 35% year-on-year jump in third-quarter net profit and declared an interim dividend.

Apollo Hospitals Enterprise Ltd shares have climbed to a fresh 52-week high after the hospital chain reported a 35% year-on-year jump in third-quarter net profit and declared an interim dividend, according to recent filings and market data.The Economic Times as of 08 May 2026MarketsMojo as of 08 May 2026

As of 09.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Apollo Hospitals Enterprise Ltd
• Sector/industry: Healthcare / Hospital & Healthcare Services
• Headquarters/country: India
• Core markets: India, with medical?tourism exposure to West Asia and other regions
• Key revenue drivers: Hospital operations, diagnostics, pharmacy, and telemedicine
• Home exchange/listing venue: National Stock Exchange of India (NSE), ticker APOLLOHOSP
• Trading currency: Indian rupee (?)

Apollo Hospitals Enterprise Ltd: core business model

Apollo Hospitals Enterprise Ltd operates one of India’s largest integrated healthcare networks, combining multi?specialty hospitals, diagnostics centers, pharmacies, and digital health platforms.Apollo Hospitals official website The group’s model focuses on volume?driven in?patient and out?patient services, supported by a growing footprint in tier?2 and tier?3 cities as well as medical?tourism hubs such as Chennai and Hyderabad.Moneycontrol as of 08 May 2026

The company also leverages its Apollo 24|7 telemedicine and digital?health platform to capture recurring revenue from subscriptions, consultations, and home?care services, which helps diversify income beyond traditional hospital admissions.Moneycontrol as of 08 May 2026 This integrated approach positions Apollo Hospitals as a key player in India’s expanding healthcare market, where rising incomes, urbanization, and government?backed insurance schemes are driving demand for private care.

Main revenue and product drivers for Apollo Hospitals Enterprise Ltd

In the third quarter of the current financial year, Apollo Hospitals reported consolidated revenue of ?6,477 crore, up 17% year?on?year, with net profit surging 35% to ?502 crore, according to an exchange filing cited by The Economic Times as of 08 May 2026. EBITDA rose 27% to ?965 crore, reflecting operating leverage from higher occupancy and improved pricing across its hospital network.

Management highlighted strong growth across all business segments, including hospitals, diagnostics, and pharmacy, as well as continued investment in advanced clinical capabilities such as organ transplants and robotic surgery.The Economic Times as of 08 May 2026 The board also declared an interim dividend of ?10 per share for the financial year 2026, signaling confidence in cash?flow generation and capital?return policy.The Economic Times as of 08 May 2026

On the stock?market front, Apollo Hospitals Enterprise Ltd shares recently traded around ?8,097 on the NSE, up about 3.3% from the previous close and near a 52?week high of roughly ?8,115, according to live data from Moneycontrol as of 08 May 2026 and MarketsMojo as of 08 May 2026. The stock’s price?to?earnings ratio stands above 50x on a trailing?12?month basis, reflecting a premium valuation versus broader Indian equities but in line with leading healthcare peers.Moneycontrol as of 08 May 2026

Conclusion

Apollo Hospitals Enterprise Ltd has delivered strong third?quarter earnings growth and a fresh 52?week high in its share price, underpinned by rising hospital volumes, higher profitability, and an interim dividend announcement.The Economic Times as of 08 May 2026MarketsMojo as of 08 May 2026 The stock trades at a premium valuation, which reflects its leadership position in India’s private healthcare sector and exposure to long?term structural tailwinds such as medical tourism and digital health.Moneycontrol as of 08 May 2026

For US investors, Apollo Hospitals Enterprise Ltd offers indirect exposure to India’s expanding healthcare market through a listed Indian equity, but with currency, regulatory, and liquidity risks typical of emerging?market small?cap to mid?cap names.NSE India as of 08 May 2026 Prospective investors should weigh the company’s solid earnings momentum against its rich valuation and the inherent volatility of Indian healthcare equities before making any decisions.Moneycontrol as of 08 May 2026

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.